TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 8 April 18, 2011
(The next issue will be on May 2, 2011)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1N_5mSvdoF2V_eJsahau8oe/
Badimon L, Storey RF, Vilahur G (2011) Update on lipids, inflammation and atherothrombosis. Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21479344
Benlakhal F, Mura T, Schved JF, Giansily-Blaizot M (2011) A retrospective analysis of 157 surgical procedures performed without replacement therapy in 83 unrelated factor VII-deficient patients. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21486425
Criado-Garcia J, Fuentes F, Cruz-Teno C, Garcia-Rios A, Jimenez-Morales A, Delgado-Lista J, . . . Perez-Jimenez F (2011) R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study. Lipids Health Dis 10:50.
http://www.ncbi.nlm.nih.gov/pubmed/21477332
Fadare O, Renshaw IL, Liang SX (2011) Expression of tissue factor and heparanase in endometrial clear cell carcinoma: possible role for tissue factor in thromboembolic events. Int J Gynecol Pathol 30:252-261.
http://www.ncbi.nlm.nih.gov/pubmed/21464728
Han CS, Xin H, Han ZG, Gao ZL (2011) [Effect of tissue factor in extravascular migration of fibrosarcoma cells.]. Zhejiang Da Xue Xue Bao Yi Xue Ban 40:184-188.
http://www.ncbi.nlm.nih.gov/pubmed/21488215
Hoppe C, Kuypers F, Larkin S, Hagar W, Vichinsky E, Styles L (2011) A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Br J Haematol.
http://www.ncbi.nlm.nih.gov/pubmed/21477202
Hwang SM, Kim JE, Han KS, Kim HK (2011) Thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation. Crit Care 15:R113.
http://www.ncbi.nlm.nih.gov/pubmed/21489300
Jakobovic J, Butkovic D, Popovic L, Bartolek D, Stanojevic M, Barcot Z (2010) Reversal of thrombocytopenia and bleeding tendency in a preterm neonate with recombinant activated factor VII: case report. Acta Clin Croat 49:309-313.
http://www.ncbi.nlm.nih.gov/pubmed/21462821
Kilinc E, van Oerle R, Borissoff JI, Oschatz C, Gerlofs-Nijland ME, Janssen NA, . . . Spronk HM (2011) Factor XII Activation is Essential to Sustain the Procoagulant Effects of Particulate Matter. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21481175
Kolucki FR, Jr., Morris GJ, Thomas LC, Scialla S (2011) Factor VII deficiency in pregnancy and delivery: a case report. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/21492323
Marchetti M, Russo L, Balducci D, Falanga A (2011) All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21458031
Marzano AV, Tedeschi A, Berti E, Fanoni D, Crosti C, Cugno M (2011) Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases. Clin Exp Immunol.
http://www.ncbi.nlm.nih.gov/pubmed/21488867
Meisel SR, Xu XP, Edgington TS, Cercek B, Ong J, Kaul S, Shah PK (2011) Dose-Dependent Modulation of Tissue Factor Protein and Procoagulant Activity in Human Monocyte-Derived Macrophages by Oxidized Low Density Lipoprotein. J Atheroscler Thromb.
http://www.ncbi.nlm.nih.gov/pubmed/21467727
Nadir Y, Kenig Y, Drugan A, Shafat I, Brenner B (2011) An assay to evaluate heparanase procoagulant activity. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21481923
Nakagomi A, Sasaki M, Ishikawa Y, Shibui T, Kosugi M, Endoh Y, . . . Mizuno K (2011) Upregulation of Monocyte Tissue Factor Activity is Significantly Associated with Carotid Intima-Media Thickness in Patients with Metabolic Syndrome. J Atheroscler Thromb.
http://www.ncbi.nlm.nih.gov/pubmed/21483174
Nurden AT (2011) Platelets, inflammation and tissue regeneration. Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21479340
Pinner NA, Hurdle AC, Oliphant C, Reaves A, Lobo B, Sills A (2010) Treatment of Warfarin-Related Intracranial Hemorrhage: A Comparison of Prothrombin Complex Concentrate and Recombinant Activated Factor VII. World Neurosurg 74:631-635.
http://www.ncbi.nlm.nih.gov/pubmed/21492631
Puy C, Hermida J, Montes R (2011) Factor X and factor VII binding to EPCR differs between species. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21489130
Schuepbach RA, Velez K, Riewald M (2011) Activated protein C upregulates procoagulant tissue factor activity on endothelial cells by shedding TFPI's Kunitz 1 domain. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/21474669
Siddiq S, Clark A, Mumford A (2011) A systematic review of the management and outcomes of pregnancy in Glanzmann thrombasthenia. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/21457404
Stephan F, Hazelzet JA, Bulder I, Boermeester MA, van Till JO, van der Poll T, . . . Zeerleder S (2011) Activation of factor VII-activating protease in human inflammation: a sensor for cell death. Crit Care 15:R110.
http://www.ncbi.nlm.nih.gov/pubmed/21466697
Tiede A, Friedrich U, Stenmo C, Allen G, Giangrande P, Goudemand J, . . . Berntorp E (2011) Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa). J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21489128
Uber WE, Toole JM, Stroud MR, Haney JS, Lazarchick J, Crawford FA, Jr., Ikonomidis JS (2011) Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular
surgery: Clinical and economic outcomes. J Thorac Cardiovasc Surg.
http://www.ncbi.nlm.nih.gov/pubmed/21457998
Wilmott RW (2011) Complications associated with off-label use of recombinant factor VIIa. J Pediatr 158:A2.
http://www.ncbi.nlm.nih.gov/pubmed/21482239
Wygrecka M, Kwapiszewska G, Jablonska E, von Gerlach S, Henneke I, Zakrzewicz D, . . . Markart P (2011) Role of Protease-Activated Receptor-2 in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med.
http://www.ncbi.nlm.nih.gov/pubmed/21471103
Yamamoto E, Nishimura N, Okada K, Sekido C, Yamamichi S, Hasumi K (2011) Inhibitors of Autoactivation of Plasma Hyaluronan-Binding Protein (Factor VII Activating Protease). Biol Pharm Bull 34:462-470.
http://www.ncbi.nlm.nih.gov/pubmed/21467630
Zhao B, Luo X, Shi H, Ma D (2011) Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21458846
Zhou H, Shi W, Zhou B, Guo D, Wang T (2010) Tissue factor-factor VIIa regulates interleukin-8, tissue factor and caspase-7 expression in SW620 cells through protease-activated receptor-2 activation. Mol Med Report 3:269-274.
http://www.ncbi.nlm.nih.gov/pubmed/21472232
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 8 April 18, 2011
(The next issue will be on May 2, 2011)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1N_5mSvdoF2V_eJsahau8oe/
Badimon L, Storey RF, Vilahur G (2011) Update on lipids, inflammation and atherothrombosis. Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21479344
Benlakhal F, Mura T, Schved JF, Giansily-Blaizot M (2011) A retrospective analysis of 157 surgical procedures performed without replacement therapy in 83 unrelated factor VII-deficient patients. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21486425
Criado-Garcia J, Fuentes F, Cruz-Teno C, Garcia-Rios A, Jimenez-Morales A, Delgado-Lista J, . . . Perez-Jimenez F (2011) R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study. Lipids Health Dis 10:50.
http://www.ncbi.nlm.nih.gov/pubmed/21477332
Fadare O, Renshaw IL, Liang SX (2011) Expression of tissue factor and heparanase in endometrial clear cell carcinoma: possible role for tissue factor in thromboembolic events. Int J Gynecol Pathol 30:252-261.
http://www.ncbi.nlm.nih.gov/pubmed/21464728
Han CS, Xin H, Han ZG, Gao ZL (2011) [Effect of tissue factor in extravascular migration of fibrosarcoma cells.]. Zhejiang Da Xue Xue Bao Yi Xue Ban 40:184-188.
http://www.ncbi.nlm.nih.gov/pubmed/21488215
Hoppe C, Kuypers F, Larkin S, Hagar W, Vichinsky E, Styles L (2011) A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Br J Haematol.
http://www.ncbi.nlm.nih.gov/pubmed/21477202
Hwang SM, Kim JE, Han KS, Kim HK (2011) Thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation. Crit Care 15:R113.
http://www.ncbi.nlm.nih.gov/pubmed/21489300
Jakobovic J, Butkovic D, Popovic L, Bartolek D, Stanojevic M, Barcot Z (2010) Reversal of thrombocytopenia and bleeding tendency in a preterm neonate with recombinant activated factor VII: case report. Acta Clin Croat 49:309-313.
http://www.ncbi.nlm.nih.gov/pubmed/21462821
Kilinc E, van Oerle R, Borissoff JI, Oschatz C, Gerlofs-Nijland ME, Janssen NA, . . . Spronk HM (2011) Factor XII Activation is Essential to Sustain the Procoagulant Effects of Particulate Matter. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21481175
Kolucki FR, Jr., Morris GJ, Thomas LC, Scialla S (2011) Factor VII deficiency in pregnancy and delivery: a case report. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/21492323
Marchetti M, Russo L, Balducci D, Falanga A (2011) All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21458031
Marzano AV, Tedeschi A, Berti E, Fanoni D, Crosti C, Cugno M (2011) Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases. Clin Exp Immunol.
http://www.ncbi.nlm.nih.gov/pubmed/21488867
Meisel SR, Xu XP, Edgington TS, Cercek B, Ong J, Kaul S, Shah PK (2011) Dose-Dependent Modulation of Tissue Factor Protein and Procoagulant Activity in Human Monocyte-Derived Macrophages by Oxidized Low Density Lipoprotein. J Atheroscler Thromb.
http://www.ncbi.nlm.nih.gov/pubmed/21467727
Nadir Y, Kenig Y, Drugan A, Shafat I, Brenner B (2011) An assay to evaluate heparanase procoagulant activity. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21481923
Nakagomi A, Sasaki M, Ishikawa Y, Shibui T, Kosugi M, Endoh Y, . . . Mizuno K (2011) Upregulation of Monocyte Tissue Factor Activity is Significantly Associated with Carotid Intima-Media Thickness in Patients with Metabolic Syndrome. J Atheroscler Thromb.
http://www.ncbi.nlm.nih.gov/pubmed/21483174
Nurden AT (2011) Platelets, inflammation and tissue regeneration. Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21479340
Pinner NA, Hurdle AC, Oliphant C, Reaves A, Lobo B, Sills A (2010) Treatment of Warfarin-Related Intracranial Hemorrhage: A Comparison of Prothrombin Complex Concentrate and Recombinant Activated Factor VII. World Neurosurg 74:631-635.
http://www.ncbi.nlm.nih.gov/pubmed/21492631
Puy C, Hermida J, Montes R (2011) Factor X and factor VII binding to EPCR differs between species. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21489130
Schuepbach RA, Velez K, Riewald M (2011) Activated protein C upregulates procoagulant tissue factor activity on endothelial cells by shedding TFPI's Kunitz 1 domain. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/21474669
Siddiq S, Clark A, Mumford A (2011) A systematic review of the management and outcomes of pregnancy in Glanzmann thrombasthenia. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/21457404
Stephan F, Hazelzet JA, Bulder I, Boermeester MA, van Till JO, van der Poll T, . . . Zeerleder S (2011) Activation of factor VII-activating protease in human inflammation: a sensor for cell death. Crit Care 15:R110.
http://www.ncbi.nlm.nih.gov/pubmed/21466697
Tiede A, Friedrich U, Stenmo C, Allen G, Giangrande P, Goudemand J, . . . Berntorp E (2011) Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa). J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21489128
Uber WE, Toole JM, Stroud MR, Haney JS, Lazarchick J, Crawford FA, Jr., Ikonomidis JS (2011) Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular
surgery: Clinical and economic outcomes. J Thorac Cardiovasc Surg.
http://www.ncbi.nlm.nih.gov/pubmed/21457998
Wilmott RW (2011) Complications associated with off-label use of recombinant factor VIIa. J Pediatr 158:A2.
http://www.ncbi.nlm.nih.gov/pubmed/21482239
Wygrecka M, Kwapiszewska G, Jablonska E, von Gerlach S, Henneke I, Zakrzewicz D, . . . Markart P (2011) Role of Protease-Activated Receptor-2 in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med.
http://www.ncbi.nlm.nih.gov/pubmed/21471103
Yamamoto E, Nishimura N, Okada K, Sekido C, Yamamichi S, Hasumi K (2011) Inhibitors of Autoactivation of Plasma Hyaluronan-Binding Protein (Factor VII Activating Protease). Biol Pharm Bull 34:462-470.
http://www.ncbi.nlm.nih.gov/pubmed/21467630
Zhao B, Luo X, Shi H, Ma D (2011) Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21458846
Zhou H, Shi W, Zhou B, Guo D, Wang T (2010) Tissue factor-factor VIIa regulates interleukin-8, tissue factor and caspase-7 expression in SW620 cells through protease-activated receptor-2 activation. Mol Med Report 3:269-274.
http://www.ncbi.nlm.nih.gov/pubmed/21472232
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
